Skip to main navigation Skip to search Skip to main content

Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study

  • C. Gallois
  • , E. S. Bergen
  • , Auclin
  • , S. Pernot
  • , J. Higué
  • , I. Trouilloud
  • , Y. Touchefeu
  • , A. Turpin
  • , T. Mazard
  • , A. Sartore-Bianchi
  • , H. Prenen
  • , A. Alberti
  • , L. Pilla
  • , S. Cuissy
  • , V. Wookey
  • , A. Perret
  • , C. Melchior
  • , P. Artru
  • , O. Dubreuil
  • , A. Drouillard
  • S. Doat, J. Lavolé, D. Basile, G. Perkins, M. Jary, S. Stintzing, J. Jos, D. Tougeron, J. Taieb

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science